Literature DB >> 1030282

Hepatitis cases in isoniazid treated groups and in a control group.

N Riska.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1030282

Source DB:  PubMed          Journal:  Bull Int Union Tuberc        ISSN: 0074-9249


× No keyword cloud information.
  13 in total

1.  Hepatotoxicity of antituberculosis drugs.

Authors:  L P Ormerod; C Skinner; J Wales
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

2.  Isoniazid hepatotoxicity requiring liver transplantation.

Authors:  Edward Sheen; Robert J Huang; Lindsay A Uribe; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2014-07       Impact factor: 3.199

3.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.

Authors:  J N Pande; S P Singh; G C Khilnani; S Khilnani; R K Tandon
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

5.  Adverse events associated with treatment of latent tuberculosis in the general population.

Authors:  Benjamin M Smith; Kevin Schwartzman; Gillian Bartlett; Dick Menzies
Journal:  CMAJ       Date:  2011-01-10       Impact factor: 8.262

6.  Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.

Authors:  J Singh; A Arora; P K Garg; V S Thakur; J N Pande; R K Tandon
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

7.  [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].

Authors:  E Musch; M Eichelbaum; J K Wang; W von Sassen; M Castro-Parra; H J Dengler
Journal:  Klin Wochenschr       Date:  1982-05-17

Review 8.  Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.

Authors:  F J Farrell; E B Keeffe; K M Man; J C Imperial; C O Esquivel
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

9.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 10.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.